STOCK-BASED COMPENSATION - Deferred Compensation Arrangement - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Deferred Compensation Arrangement with Employees and Non-Employees, Share-Based Payments [Line Items]
Research and development	$ 157,187,000	$ 130,481,000	$ 117,062,000
Non-Employee Members of Scientific Advisory Board [Member]
Deferred Compensation Arrangement with Employees and Non-Employees, Share-Based Payments [Line Items]
Shares issued (in shares)	1,616	2,366
Research and development	$ 242,000	$ 248,000	$ 234,000
Members of Scientific Advisory Board [Member]
Deferred Compensation Arrangement with Employees and Non-Employees, Share-Based Payments [Line Items]
Fair value of shares issued	$ 300,000	$ 300,000